| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Carcinoma, Oat Cell
[description not available] | 0 | 3.8 | 2 | 1 |
Diffuse Mixed Small and Large Cell Lymphoma
[description not available] | 0 | 2.67 | 3 | 0 |
Lymphoma, Non-Hodgkin
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. | 0 | 2.67 | 3 | 0 |
Rhabdomyosarcoma
A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9) | 0 | 2.39 | 2 | 0 |
Carcinoma, Small Cell
An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7) | 0 | 3.8 | 2 | 1 |
Benign Neoplasms
[description not available] | 0 | 1.96 | 1 | 0 |
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 1.96 | 1 | 0 |
Leukemia L 1210
[description not available] | 0 | 3.06 | 5 | 0 |
Malignant Melanoma
[description not available] | 0 | 2.66 | 3 | 0 |
Experimental Mammary Neoplasms
[description not available] | 0 | 2.66 | 3 | 0 |
Melanoma
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) | 0 | 2.66 | 3 | 0 |
Anaphylactic Reaction
[description not available] | 0 | 1.96 | 1 | 0 |
Anaphylaxis
An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. | 0 | 1.96 | 1 | 0 |
Experimental Leukemia
[description not available] | 0 | 1.96 | 1 | 0 |
Cancer of Lung
[description not available] | 0 | 3.39 | 1 | 1 |
Local Neoplasm Recurrence
[description not available] | 0 | 3.39 | 1 | 1 |
Lung Neoplasms
Tumors or cancer of the LUNG. | 0 | 3.39 | 1 | 1 |
Granulocytic Leukemia, Chronic
[description not available] | 0 | 1.97 | 1 | 0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. | 0 | 1.97 | 1 | 0 |
Kahler Disease
[description not available] | 0 | 1.97 | 1 | 0 |
Diffuse Large B-Cell Lymphoma
[description not available] | 0 | 1.97 | 1 | 0 |
Multiple Myeloma
A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. | 0 | 1.97 | 1 | 0 |
Lymphoma, Large B-Cell, Diffuse
Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. | 0 | 1.97 | 1 | 0 |
Thrombopenia
[description not available] | 0 | 1.97 | 1 | 0 |
Anemia
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. | 0 | 1.97 | 1 | 0 |
Neutropenia
A decrease in the number of NEUTROPHILS found in the blood. | 0 | 1.97 | 1 | 0 |
Thrombocytopenia
A subnormal level of BLOOD PLATELETS. | 0 | 1.97 | 1 | 0 |
Adenocarcinoma, Basal Cell
[description not available] | 0 | 1.97 | 1 | 0 |
Leucocythaemia
[description not available] | 0 | 1.97 | 1 | 0 |
Osteogenic Sarcoma
[description not available] | 0 | 1.97 | 1 | 0 |
Animal Mammary Carcinoma
[description not available] | 0 | 1.97 | 1 | 0 |
Adenocarcinoma
A malignant epithelial tumor with a glandular organization. | 0 | 1.97 | 1 | 0 |
Leukemia
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) | 0 | 1.97 | 1 | 0 |
Osteosarcoma
A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) | 0 | 1.97 | 1 | 0 |
Metastase
[description not available] | 0 | 1.97 | 1 | 0 |
Neoplasm Metastasis
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. | 0 | 1.97 | 1 | 0 |
Graft-Versus-Host Disease
[description not available] | 0 | 1.97 | 1 | 0 |
Delayed Hypersensitivity
[description not available] | 0 | 1.97 | 1 | 0 |
Infections, Pseudomonas
[description not available] | 0 | 1.97 | 1 | 0 |
Graft vs Host Disease
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. | 0 | 1.97 | 1 | 0 |
Pseudomonas Infections
Infections with bacteria of the genus PSEUDOMONAS. | 0 | 1.97 | 1 | 0 |
Experimental Neoplasms
[description not available] | 0 | 2.37 | 2 | 0 |